Quantitative Model Analysis and Simulation of Pharmacokinetics and<i>Metastasis-Associated Lung Adenocarcinoma 1</i>RNA Knockdown Effect After Systemic Administration of Cholesterol-Conjugated DNA/RNA Heteroduplex Oligonucleotide Crossing Blood–Brain Barrier of Mice-Reference-Cited by-同舟云学术

Quantitative Model Analysis and Simulation of Pharmacokinetics andMetastasis-Associated Lung Adenocarcinoma 1RNA Knockdown Effect After Systemic Administration of Cholesterol-Conjugated DNA/RNA Heteroduplex Oligonucleotide Crossing Blood–Brain Barrier of Mice

Published:2022-10-23 Issue:1 Volume:384 Page:197-204
ISSN:0022-3565
Container-title:Journal of Pharmacology and Experimental Therapeutics
language:en
Short-container-title:J Pharmacol Exp Ther

Author:

Goto Akihiko^ORCID,Yamamoto Syunsuke,Igari Tomoko,Matsumoto Shin-ichi,Chisaki Ikumi,Iida Koichi,Nakayama Miyu,Oda Akira,Kakoi Yuuichi,Uchida Akio,Miyata Kenichi,Nishikawa Makiya,Nagata Tetsuya,Kusuhara Hiroyuki,Yokota Takanori,Hirabayashi Hideki

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference34 articles.

1. Structure and function of the blood–brain barrier

2. A Semi-Mechanistic Population Pharmacokinetic Model of Nusinersen: An Antisense Oligonucleotide for the Treatment of Spinal Muscular Atrophy;Biliouris;CPT Pharmacometrics Syst Pharmacol,2018

3. Visualization of Chemokine Binding Sites on Human Brain Microvessels

4. Next generation antibody drugs: pursuit of the ‘high-hanging fruit’;Carter;Nat Rev Drug Discov,2018

5. Blood-Brain Barrier Permeability Is Regulated by Lipid Transport-Dependent Suppression of Caveolae-Mediated Transcytosis

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. DMPK perspective on quantitative model analysis for chimeric antigen receptor cell therapy: Advances and challenges;Drug Metabolism and Pharmacokinetics;2024-06

2. Biodistribution and delivery of oligonucleotide therapeutics to the central nervous system: Advances, challenges, and future perspectives;Biopharmaceutics & Drug Disposition;2022-11-16